ABBOTT LABORATORIES·4

Feb 23, 7:20 PM ET

WHITE MILES D 4

4 · ABBOTT LABORATORIES · Filed Feb 23, 2021

Insider Transaction Report

Form 4
Period: 2021-02-19
WHITE MILES D
DirectorChairman and CEO
Transactions
  • Award

    Common shares without par value

    2021-02-19+44,3403,148,487 total
  • Award

    Option (right to buy)

    2021-02-19+227,272227,272 total
    Exercise: $124.04From: 2022-02-19Exp: 2031-02-18Common Shares (227,272 underlying)
  • Gift

    Common shares without par value

    2021-02-162,0003,104,147 total
Holdings
  • Common shares without par value

    (indirect: By Trust)
    35,404
Footnotes (3)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 19, 2021.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 75,757 on February 19, 2022, 75,757 on February 19, 2023, and 75,758 on February 19, 2024.

Documents

1 file
  • 4
    form4-02232021_040231.xmlPrimary